Professor, Neurology, UC, Davis School of Medicine
Neurology
Dr. Mark A. Agius, MD
|
|
Give Review
Mark Agius practices Neurology. He researched medicine at University of Malta School of Medicine. Mark Agius is also published. He has 100 publications published. The lastest publication: "Morvan''s fibrillary chorea: a paraneoplastic manifestation of thymoma.' Doctor Mark A. Agius, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Safety and efficacy of fingolimod in patients with relapsing-remitting Multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
- Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
- Mechanisms of action of ACTH in the management of relapsing forms of Multiple sclerosis.
- Fingolimod Therapy in Early Multiple Sclerosis: An Efficacy Analysis of the TRANSFORMS and FREEDOMS Studies by Time Since First Symptom.
- Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren's Syndrome.
- Genome wide differences of gene expression associated with HLA-DRB1 genotype in Multiple sclerosis: A pilot study.
- Acute Severe Animal Model of Anti-Muscle-Specific Kinase Myasthenia: Combined Postsynaptic and Presynaptic Changes.
- Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice.
- Clinical and neuroimaging assessments for research studies (including drug trials) in Multiple sclerosis.
- Current approved options for treating patients with Multiple sclerosis.
- Treatment of autoimmune Myasthenia gravis.
- Introduction. Biochemical basis for Disease of the neuromuscular junction.
- Treatment principles in the management of autoimmune Myasthenia gravis.
- Agonist-induced transitions of the acetylcholine receptor.
- Three forms of immune Myasthenia.
- Using non-steroidal anti-Inflammatory drugs in the treatment of depression.
- Secondary enuresis & body dysmorphic disorder in a caucasian male with catatonic schizophrenia: a case report.
- Meta-analysis of medical and non-medical treatments of the prodromal phase of psychotic illness in at-risk mental states.
- An audit to identify factors affecting response to treatment among depressed patients who have documented suicidal ideation/attempts in a Bedfordshire Community Mental...
- Does early intervention for psychosis work? An analysis of outcomes of early intervention in psychosis based on the critical period hypothesis, measured by number of a...
- An audit to identify factors that are more commonly associated with depressed patients on augmentation therapy under the Befordshire East Community Mental Health Team ...
- Bipolar disorder associated with paraneoplastic cerebellar Degeneration: a case report.
- A care pathway for schizophrenia.
- Further development of early intervention in psychosis.
- Depression management.
- Editorial: on neuroscience, epidemiology, pharmacotherapy, recovery, treatment resistance, and community mental health teams.
- Prevalence of co-morbid bipolar disorder and Migraine in a regional hospital psychiatric outpatient department.
- Mixed affective states: a study within a community mental health team with treatment recommendations.
- Depression management - from neurobiology to a shared care approach.
- Differences between training GPs to manage depression in primary care and issuing them with guidelines, and a system of collaborative care in the treatment of depressi...
- Post-traumatic stress disorder (PTSD) treatment experience in Bedford East - audit and reaudit.
- Co-morbidity of bipolar affective disorder and obsessive compulsive disorder in a Bedford community psychiatry team.
- The Kraepelinian dichotomy in terms of employment outcomes.
- Neurobiology of bipolar disorder - lessons from migraine Disorders.
- An audit to compare patient factors (age, sex, social Background & associated physical diagnoses) in people with refractory depression in a Bedfordshire Community Ment...
- An audit to compare the efficacy of treatment (as indicated by discharge rates and reduction in suicidality) among patients with refractory depression in a Bedfordshir...
- How frequently are atypical antipsychotics used to treat OCD in a British community mental health team?
- Review: response to antipsychotics in schizophrenia in published trials of limited clinical significance.
- Rapsyn mutations in myasthenic Syndrome due to impaired receptor clustering.
- Early intervention in psychosis.
- Basic standards for management of patients with common mental illnesses in primary care.
- Basic standards for management of patients with serious mental illness in the community.
- The use of card sort exercises in the prevention of relapse in serious mental illness.
- The development of a Leonardo Program for teaching community psychiatry.
- "My new Alfa Romeo GT is not in the garage any more": Cognitive behavioural therapy of panic disorder with agoraphobia co morbid with psychosis.
- Group psychotherapy for parents of patients with schizophrenia.
- The role of the primary care mental health worker.
- Developing primary care treatment of depression.
- An early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Basic concepts...
- Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental heal...
- Atypical antipsychotic prescribing and diabetes.
- The patient with schizophrenia and his father. The father''s role and personality traits in the dynamics of the family with a son suffering from schizophrenia.
- A study of the incidence of bipolar spectrum Disorders in a private psychiatric practice.
- "Since I have my case manager, I am Back to life" case management in Croatia.
- The clinical dilemma--prescribing in pregnancy.
- The ethics of identifying and treating psychosis early.
- Duration of untreated psychosis and it''s effect on the functional outcome in schizophrenia - preliminary results.
- On patient centred psychiatry.
- Three year outcomes in an early intervention service for psychosis in a multicultural and multiethnic population.
- Wake-up call for British psychiatry: responses.
- Duration of untreated psychosis and it''s effect on the symptomatic recovery in schizophrenia - preliminary results.
- Phenomenology of PTSD and psychotic symptoms.
- Is psychiatry a religion? An alternative view.
- Early intervention in psychosis. Concepts and service development.
- Psychological treatments and brain biology.
- Is oestrogen neuroprotective?
- The child as the presenting symptom, and what happens when things go wrong?
- Soft neurological signs and schizophrenia - a looking glass into core pathology?
- The epidemiology of psychosis in Luton.
- Developing outcome measures for serious mental illness; using early intervention as an example.
- The development of community treatment in Slovenia - first outcomes.
- The stress-vulnerability model how does stress impact on mental illness at the level of the brain and what are the consequences?
- The staging model in schizophrenia, and its clinical implications.
- Issues regarding the delivery of early intervention psychiatric services to the South Asian population in England.
- Depression Treatment by Bedford East Community Mental Health Team an Audit to assess how many patients in a Bedfordshire Community Mental Health Team might safely be t...
- What do large scale studies of medication in schizophrenia add to our management strategies?
- An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
- An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
- Suicide risk and choice of antidepressant.
- The dramatic effects of Galantamine in a patient with early-onset Alzheimer''s Disease.
- A comparison of outcomes of patients with depression, recurrent depression, and depression and anxiety within patients in a British CMHT.
- The bipolar spectrum: do we need a single algorithm for affective Disorders?
- FMR1 premutation in females diagnosed with Multiple sclerosis.
- An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with Multiple sclerosis.
- Rapsyn antibodies in Myasthenia gravis.
- Antibodies to AChR, synapse-organizing proteins, titin, and other muscle proteins in Morvan's fibrillary chorea.
- Antirapsyn antibodies occur commonly in patients with lupus.
- Antirapsyn antibodies in Chronic procainamide-associated myopathy (CPAM).
- Effect of anti-idiotopic antibody on the course of experimental autoimmune Myasthenia gravis.
- Morvan''s fibrillary chorea: a paraneoplastic manifestation of thymoma.
- High prevalence of anti-alpha-crystallin antibodies in multiple sclerosis: correlation with severity and activity of Disease.
- Noninflammatory immune mechanisms in Diseases of the nervous system.
- Monoclonal anti-idiotopic antibodies against Myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies af...
- Suppression of development of experimental autoimmune Myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody.
- Refractoriness to a second episode of experimental Myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
- Human x human hybridomas from patients with Myasthenia gravis: possible tools for idiotypic therapy for Myasthenia.
- Myasthenia gravis: pathogenesis and treatment.
- Acquired Myasthenia gravis. Immunopathology.
- Effector mechanisms of myasthenic antibodies.
Procedures Preformed
- EMG (Electromyography)
Conditions Treated
- Alzheimer's Background: yellow;'>Background: yellow;'>Disease
- Anterior Horn Background: yellow;'>Background: yellow;'>Disease
- Ataxia
- Autonomic Background: yellow;'>Background: yellow;'>Background: yellow;'>Disorders
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Education
-
Boston University Medical Center -
University of Malta School of Medicine
Hospital
-
University of California, Davis Medical Center
Drug Facts
| NPI NUMBER | 1003897349 | |
| NPPES Provider LastName | AGIUS | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 95817 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurology | |
| Total Claim Count | 817.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003897349 |
| Last Name Of The Provider | AGIUS |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Paul T. Akins, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bjorn E. Oskarsson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara J. Gardner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank R. Sharp, MD |
|
|
Dr. Howard M. Slyter Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barry R. Tharp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mustafa K. Ansari, MD |
|
|
Dr. Rebecca S. Jordan, MD |